Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus-based vectors that replicate in rodent cells

P J Krysan1, M P Calos

  • 1Department of Genetics, Stanford University School of Medicine, CA 94305.

Gene
|December 22, 1993
PubMed
Summary

Researchers developed novel autonomously replicating vectors for rodent cells using Epstein-Barr virus (EBV) components. These stable, extrachromosomal plasmids offer a new tool for genetic studies in organisms lacking such systems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome Editing Techniques and Their Therapeutic Applications.

Clinical pharmacology and therapeutics·2016
Same author

Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy.

Gene therapy·2011
Same author

Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity.

Gene therapy·2009
Same author

Directed evolution of a recombinase for improved genomic integration at a native human sequence.

Nucleic acids research·2002
Same author

Phage R4 integrase mediates site-specific integration in human cells.

Gene·2001
Same author

Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Area of Science:

  • Molecular Biology
  • Genetics
  • Virology

Background:

  • Epstein-Barr virus (EBV)-based vectors are effective for primate cell studies.
  • Existing EBV vectors do not replicate in rodent cells, limiting their application.

Purpose of the Study:

  • To engineer EBV-based vectors capable of autonomous replication and stable maintenance in rodent cells.
  • To establish a novel class of stable, extrachromosomal plasmids for genetic manipulation in non-primate mammalian systems.

Main Methods:

  • Modified EBV vectors by incorporating the EBNA-1 gene and EBV family of repeats.
  • Added large fragments of mammalian DNA to enhance vector stability and replication.
  • Utilized density-shift assays in Cs2SO4 density gradients to assess plasmid replication.

Related Experiment Videos

Main Results:

  • Generated autonomously replicating vectors stably maintained as extrachromosomal plasmids in hamster cells.
  • Demonstrated high-efficiency, once-per-cell-cycle replication of these plasmids.
  • Established the first class of stable, autonomous vectors with once-per-cell-cycle replication for rodent cells.

Conclusions:

  • Mammalian DNA fragments enable EBV-based vector replication and stable maintenance in rodent cells.
  • These novel vectors provide a unique tool for genetic studies in rodent models.
  • The EBV-based autonomous replication system has potential applications in other organisms lacking stable plasmid systems.